Hospital Volume and 30-Day Mortality for Three Common Medical Conditions

The association between hospital volume and patient mortality has been established for some surgical procedures but is unclear for medical conditions. In this analysis of claims data from Medicare beneficiaries who were hospitalized for acute myocardial infarction, heart failure, or pneumonia, admis...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 362; no. 12; pp. 1110 - 1118
Main Authors Ross, Joseph S, Normand, Sharon-Lise T, Wang, Yun, Ko, Dennis T, Chen, Jersey, Drye, Elizabeth E, Keenan, Patricia S, Lichtman, Judith H, Bueno, Héctor, Schreiner, Geoffrey C, Krumholz, Harlan M
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 25.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The association between hospital volume and patient mortality has been established for some surgical procedures but is unclear for medical conditions. In this analysis of claims data from Medicare beneficiaries who were hospitalized for acute myocardial infarction, heart failure, or pneumonia, admission to higher-volume hospitals was associated with lower mortality. In this analysis of claims data from Medicare beneficiaries who were hospitalized for acute myocardial infarction, heart failure, or pneumonia, admission to higher-volume hospitals was associated with lower mortality. The relationship between hospital volume and patient mortality for acute myocardial infarction, heart failure, and pneumonia in the United States is unclear. Admission to higher-volume hospitals has been associated with a reduction in mortality for numerous surgical conditions and medical procedures 1 but not for common medical conditions. Two studies examining acute myocardial infarction showed that admission to higher-volume hospitals was associated with reduced mortality, 2 , 3 although both studies were performed before the adoption of improvements in computational power that account for the clustering of patients' outcomes within hospitals and key advances in clinical cardiology, including the widespread use of fibrinolytic . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMsa0907130